Sequencing of the IL6 gene in a case-control study of cerebral palsy in children

BMC Medical Genetics

Volumn 14, Issue 1, 2013, Pages

  Khankhanian, Pouya ^a   Baranzini, Sergio E ^a   Johnson, Britt A ^a   Madireddy, Lohith ^a   Nickles, Dorothee ^a   Croen, Lisa A ^b   Wu, Yvonne W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DIVISION OF RESEARCH   (United States)

Author keywords

Cerebral palsy; Haplotype; IL 6; Interleukin 6; Sanger sequencing

Indexed keywords

INTERLEUKIN 6;

ARTICLE; CASE CONTROL STUDY; CEREBRAL PALSY; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC PROCEDURES; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HEMIPARESIS; HUMAN; INFANT; INHERITANCE; INTERLEUKIN 6 GENE; MAJOR CLINICAL STUDY; MALE; PARAPLEGIA; PROMOTER REGION; QUADRIPLEGIA; SANGER SEQUENCING; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; CEREBRAL PALSY; FRAMESHIFT MUTATION; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTERLEUKIN-6; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 84889077850     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-14-126     Document Type: Article

References (31)

1. Rosenbaum P. The natural history of gross motor development in children with cerebral palsy aged 1 to 15 years. Dev Med Child Neurol 2007, 49(10):724. 10.1111/j.1469-8749.2007.00724.x, 17880638.
2. Wu YW, Escobar GJ, Grether JK, Croen LA, Greene JD, Newman TB. Chorioamnionitis and cerebral palsy in term and near-term infants. JAMA 2003, 290(20):2677-2684. 10.1001/jama.290.20.2677, 14645309.
3. Vigneswaran R, Aitchison SJ, McDonald HM, Khong TY, Hiller JE. Cerebral palsy and placental infection: a case-cohort study. BMC Pregnancy Childbirth 2004, 4(1):1. 10.1186/1471-2393-4-1, 343280, 15005809.
4. Grether JK, Nelson KB. Maternal infection and cerebral palsy in infants of normal birth weight. JAMA 1997, 278(3):207-211. 10.1001/jama.1997.03550030047032, 9218666.
5. Hemminki K, Li X, Sundquist K, Sundquist J. High familial risks for cerebral palsy implicate partial heritable aetiology. Paediatr Perinat Epidemiol 2007, 21(3):235-241. 10.1111/j.1365-3016.2007.00798.x, 17439532.
6. Nelson KB, Grether JK. Causes of cerebral palsy. Curr Opin Pediatr 1999, 11(6):487-491. 10.1097/00008480-199912000-00002, 10590904.
7. Nelson KB, Lynch JK. Stroke in newborn infants. Lancet Neurol 2004, 3(3):150-158. 10.1016/S1474-4422(04)00679-9, 14980530.
8. Gibson CS, Maclennan AH, Dekker GA, Goldwater PN, Sullivan TR, Munroe DJ, Tsang S, Stewart C, Nelson KB. Candidate genes and cerebral palsy: a population-based study. Pediatrics 2008, 122(5):1079-1085. 10.1542/peds.2007-3758, 18977990.
9. Gibson CS, MacLennan AH, Goldwater PN, Haan EA, Priest K, Dekker GA. The association between inherited cytokine polymorphisms and cerebral palsy. Am J Obstet Gynecol 2006, 194(3):674 e671-611.
10. Moreno-De-Luca A, Ledbetter DH, Martin CL. Genetic insights into the causes and classification of cerebral palsies. Lancet Neurol 2012, 11(3):283-292. 10.1016/S1474-4422(11)70287-3, 3296129, 22261432.
11. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998, 102(7):1369-1376. 10.1172/JCI2629, 508984, 9769329.
12. Huth C, Heid IM, Vollmert C, Gieger C, Grallert H, Wolford JK, Langer B, Thorand B, Klopp N, Hamid YH, et al. IL6 gene promoter polymorphisms and type 2 diabetes: joint analysis of individual participants' data from 21 studies. Diabetes 2006, 55(10):2915-2921. 10.2337/db06-0600, 17003362.
13. Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000, 275(24):18138-18144. 10.1074/jbc.M000379200, 10747905.
14. Nokso-Koivisto J, Patel JA, Chonmaitree T. IL-6-174 c/c genotype is not conclusively a low IL-6 production phenotype. J Infect Dis 2011, 203(12):1876-1878. 10.1093/infdis/jir181, 3100513, 21606547.
15. Djukic M, Gibson CS, Maclennan AH, Goldwater PN, Haan EA, McMichael G, Priest K, Dekker GA, Hague WM, Chan A, et al. Genetic susceptibility to viral exposure may increase the risk of cerebral palsy. Aust N Z J Obstet Gynaecol 2009, 49(3):247-253. 10.1111/j.1479-828X.2009.00999.x, 19566553.
16. Wu D, Zou YF, Xu XY, Feng XL, Yang L, Zhang GC, Bu XS, Tang JL. The association of genetic polymorphisms with cerebral palsy: a meta-analysis. Dev Med Child Neurol 2011, 53(3):217-225. 10.1111/j.1469-8749.2010.03884.x, 21291465.
17. Wu YW, Croen LA, Torres AR, Van De Water J, Grether JK, Hsu NN. Interleukin-6 genotype and risk for cerebral palsy in term and near-term infants. Ann Neurol 2009, 66(5):663-670. 10.1002/ana.21766, 19938160.
18. Martin-Ancel A, Garcia-Alix A, Pascual-Salcedo D, Cabanas F, Valcarce M, Quero J. Interleukin-6 in the cerebrospinal fluid after perinatal asphyxia is related to early and late neurological manifestations. Pediatrics 1997, 100(5):789-794. 10.1542/peds.100.5.789, 9346977.
19. Nelson KB, Dambrosia JM, Grether JK, Phillips TM. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 1998, 44(4):665-675. 10.1002/ana.410440413, 9778266.
20. Yoon BH, Jun JK, Romero R, Park KH, Gomez R, Choi JH, Kim IO. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997, 177(1):19-26. 10.1016/S0002-9378(97)70432-0, 9240577.
21. Yoon BH, Romero R, Kim CJ, Koo JN, Choe G, Syn HC, Chi JG. High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia. Am J Obstet Gynecol 1997, 177(2):406-411. 10.1016/S0002-9378(97)70206-0, 9290459.
22. Yoon BH, Romero R, Yang SH, Jun JK, Kim IO, Choi JH, Syn HC. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 1996, 174(5):1433-1440. 10.1016/S0002-9378(96)70585-9, 9065108.
23. Duggan PJ, Maalouf EF, Watts TL, Sullivan MH, Counsell SJ, Allsop J, Al-Nakib L, Rutherford MA, Battin M, Roberts I, et al. Intrauterine T-cell activation and increased proinflammatory cytokine concentrations in preterm infants with cerebral lesions. Lancet 2001, 358(9294):1699-1700. 10.1016/S0140-6736(01)06723-X, 11728550.
24. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. A method and server for predicting damaging missense mutations. Nat Methods 2010, 7(4):248-249. 10.1038/nmeth0410-248, 2855889, 20354512.
25. Goldman M, Craft B, Swatloski T, Ellrott K, Cline M, Diekhans M, Ma S, Wilks C, Stuart J, Haussler D, et al. The UCSC cancer genomics browser: update, 2013. Nucleic Acids Res 2013,
26. Hartigan JA. Clustering Algorithms 1975, New York: Wiley.
27. Maunakea AK, Nagarajan RP, Bilenky M, Ballinger TJ, D'Souza C, Fouse SD, Johnson BE, Hong C, Nielsen C, Zhao Y, et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 2010, 466(7303):253-257. 10.1038/nature09165, 20613842.
28. Karppinen J, Daavittila I, Noponen N, Haapea M, Taimela S, Vanharanta H, Ala-Kokko L, Mannikko M. Is the interleukin-6 haplotype a prognostic factor for sciatica?. Eur J Pain 2008, 12(8):1018-1025. 10.1016/j.ejpain.2008.01.009, 18321738.
29. Sousa AL, Fava VM, Sampaio LH, Martelli CM, Costa MB, Mira MT, Stefani MM. Genetic and immunological evidence implicates interleukin 6 as a susceptibility gene for leprosy type 2 reaction. J Infect Dis 2012, 205(9):1417-1424. 10.1093/infdis/jis208, 22459738.
30. Chen M, Li T, Lin S, Bi D, Zhu D, Shang Q, Ma C, Wang H, Wang L, Zhang Y, et al. Association of inter leukin 6 gene polymorph isms w ith genetic susceptibili ties to spas tic tetraplegi a in males : a case-control study. Cytokine 2013, In Press.
31. Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z, Freeman C, Hunt SE, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011, 476(7359):214-219. 10.1038/nature10251, 3182531, 21833088.